Positron Corp. (OTCMKTS:POSC) Stock Short Interest Climbs 58.4%

Positron Corp. (OTCMKTS:POSC) was the target of a large growth in short interest in September. As of September 30th, there was short interest totaling 9,086 shares, a growth of 58.4% from the September 15th total of 5,736 shares. Approximately 0.0% of the company’s shares are short sold. Based on an average trading volume of 52,650 shares, the short-interest ratio is presently 0.2 days.

Positron Price Performance

Shares of OTCMKTS:POSC remained flat at $1.62 during trading on Friday. 48,927 shares of the stock were exchanged, compared to its average volume of 22,467. The company has a market capitalization of $53.62 million, a price-to-earnings ratio of -5.06 and a beta of 0.53. The business’s 50-day simple moving average is $1.75 and its two-hundred day simple moving average is $1.77. Positron has a fifty-two week low of $1.27 and a fifty-two week high of $2.74.

Positron (OTCMKTS:POSC) last announced its quarterly earnings results on Friday, August 14th. The company reported ($0.03) earnings per share (EPS) for the quarter. Positron had a negative net margin of 2,279.55% and a negative return on equity of 2,415.88%. The firm had revenue of $0.11 million during the quarter.

About Positron

Positron Corporation is a medical device company focused on positron emission tomography (PET), an imaging technology used to evaluate physiological and metabolic activity in the body. The company develops, manufactures and distributes PET imaging systems and related products for the nuclear medicine market.

Its product focus has included dedicated PET systems designed for applications such as cardiac imaging, as well as technologies intended to support the diagnosis and management of cardiovascular disease, cancer and other medical conditions.